The Advisory Team at Azura Ophthalmics comprises industry experts who provide strategic guidance on the development and commercialization of treatments for Meibomian gland dysfunction and Dry Eye Disease. Leveraging their extensive knowledge and networks, the team advises on clinical trial design, regulatory pathways, and market entry strategies to ensure the successful advancement of Azura's innovative portfolio.
View all